First Horizon Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$33.6M Buy
120,365
+4,317
+4% +$1.22M 0.87% 32
2025
Q1
$36.2M Buy
116,048
+60,577
+109% +$17.9M 1.02% 24
2024
Q4
$14.5M Sell
55,471
-5,298
-9% -$1.57M 0.41% 74
2024
Q3
$19.6M Buy
60,769
+1,872
+3% +$612K 0.54% 65
2024
Q2
$18.4M Buy
58,897
+416
+0.7% +$122K 0.56% 58
2024
Q1
$16.6M Buy
58,481
+17,182
+42% +$5.03M 0.51% 64
2023
Q4
$11.9M Sell
41,299
-995
-2% -$271K 0.39% 83
2023
Q3
$11.4M Sell
42,294
-2,268
-5% -$566K 0.41% 81
2023
Q2
$9.89M Buy
44,562
+754
+2% +$175K 0.34% 94
2023
Q1
$10.6M Sell
43,808
-392
-0.9% -$96.2K 0.38% 84
2022
Q4
$11.6M Sell
44,200
-1,887
-4% -$506K 0.43% 72
2022
Q3
$10.4M Sell
46,087
-1,652
-3% -$400K 0.42% 76
2022
Q2
$11.6M Buy
47,739
+12,014
+34% +$2.94M 0.41% 75
2022
Q1
$8.64M Sell
35,725
-9,649
-21% -$2.22M 0.47% 68
2021
Q4
$10.2M Sell
45,374
-825
-2% -$174K 0.31% 100
2021
Q3
$9.82M Buy
46,199
+18,014
+64% +$4.15M 0.32% 96
2021
Q2
$6.87M Sell
28,185
-370
-1% -$91K 0.37% 79
2021
Q1
$7.1M Sell
28,555
-199
-0.7% -$47.5K 0.41% 73
2020
Q4
$6.61M Sell
28,754
-207
-0.7% -$47.7K 0.44% 68
2020
Q3
$7.36M Sell
28,961
-1,198
-4% -$297K 0.55% 57
2020
Q2
$7.11M Sell
30,159
-36
-0.1% -$8.21K 0.56% 56
2020
Q1
$6.12M Sell
30,195
-1,156
-4% -$253K 0.57% 49
2019
Q4
$7.56M Sell
31,351
-383
-1% -$84.4K 0.56% 52
2019
Q3
$6.14M Buy
31,734
+78
+0.2% +$15K 0.48% 56
2019
Q2
$5.83M Buy
31,656
+65
+0.2% +$11.6K 0.45% 59
2019
Q1
$6M Sell
31,591
-622
-2% -$119K 0.48% 58
2018
Q4
$6.27M Sell
32,213
-251
-0.8% -$49K 0.56% 51
2018
Q3
$6.73M Sell
32,464
-895
-3% -$176K 0.52% 58
2018
Q2
$6.16M Sell
33,359
-227
-0.7% -$40.2K 0.52% 60
2018
Q1
$5.73M Sell
33,586
-673
-2% -$124K 0.56% 56
2017
Q4
$6.04M Sell
34,259
-261
-0.8% -$46.2K 0.57% 59
2017
Q3
$6.44M Buy
34,520
+258
+0.8% +$45.7K 0.66% 46
2017
Q2
$5.91M Buy
34,262
+15,552
+83% +$2.53M 0.64% 49
2017
Q1
$3.06M Buy
18,710
+16,652
+809% +$2.77M 0.35% 87
2016
Q4
$340K Hold
2,058
0.04% 249
2016
Q3
$340K Buy
2,058
+354
+21% +$59.9K 0.04% 245
2016
Q2
$258K Hold
1,704
0.04% 267
2016
Q1
$256K Buy
1,704
+50
+3% +$7.43K 0.03% 285
2015
Q4
$268K Sell
1,654
-154
-9% -$24.2K 0.05% 239
2015
Q3
$249K Buy
1,808
+81
+5% +$12.8K 0.04% 257
2015
Q2
$265K Sell
1,727
-3,089
-64% -$495K 0.04% 264
2015
Q1
$770K Buy
4,816
+3,100
+181% +$488K 0.11% 181
2014
Q4
$273K Sell
1,716
-612
-26% -$95.4K 0.04% 274
2014
Q3
$327K Hold
2,328
0.05% 241
2014
Q2
$278K Sell
2,328
-293
-11% -$33.9K 0.04% 288
2014
Q1
$322K Sell
2,621
-414
-14% -$50.2K 0.05% 259
2013
Q4
$346K Sell
3,035
-25
-0.8% -$2.84K 0.05% 241
2013
Q3
$342K Buy
3,060
+2,753
+897% +$299K 0.06% 228
2013
Q2
$30K Buy
+307
New +$31.9K 0.02% 278

Other funds holding AMGN

First Horizon Advisors's AMGN Position: Q2 2025 in Review

First Horizon Advisors increased its Amgen (AMGN) stake by 3.7% in Q2 2025, buying an estimated $1.22M and bringing the position to 120,365 shares worth $33.6M. The position accounts for 0.87% of the portfolio, ranked #32.

First Horizon Advisors first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $36.2M in Q1 2025. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • First Horizon Advisors held 120,365 shares of Amgen worth $33.6M as of Q2 2025.
  • First Horizon Advisors bought 4,317 Amgen shares in Q2 2025, an estimated $1.22M.
  • Amgen made up 0.87% of First Horizon Advisors's portfolio in Q2 2025, its #32 holding.
  • First Horizon Advisors first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
  • First Horizon Advisors's Amgen position peaked at $36.2M in Q1 2025.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.